Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Modeling the “Bomb-Like” Dynamics of COVID-19 with Undetected Transmissions and the Implications for Policy

View ORCID ProfileGary Lin, Anindya Bhaduri, Alexandra T. Strauss, Maxwell Pinz, View ORCID ProfileDiego A. Martinez, Katie K. Tseng, Oliver Gatalo, View ORCID ProfileAndrew T. Gaynor, View ORCID ProfileEfrain Hernandez-Rivera, Emily Schueller, Yupeng Yang, Simon A. Levin, Eili Y. Klein, For the CDC MInD-Healthcare Program
doi: https://doi.org/10.1101/2020.04.05.20054338
Gary Lin
1Department of Emergency Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
2Center for Data Science in Emergency Medicine, Johns Hopkins University, Baltimore, MD, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gary Lin
  • For correspondence: glin15@jhu.edu
Anindya Bhaduri
3Department of Civil and Systems Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra T. Strauss
2Center for Data Science in Emergency Medicine, Johns Hopkins University, Baltimore, MD, USA
4Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
MD, MIE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maxwell Pinz
3Department of Civil and Systems Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diego A. Martinez
1Department of Emergency Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
2Center for Data Science in Emergency Medicine, Johns Hopkins University, Baltimore, MD, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Diego A. Martinez
Katie K. Tseng
5Center for Disease Dynamics, Economics, and Policy, Silver Spring, MD, USA
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Gatalo
6U.S. Army Research Laboratory, Aberdeen, MD, USA
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew T. Gaynor
6U.S. Army Research Laboratory, Aberdeen, MD, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew T. Gaynor
Efrain Hernandez-Rivera
6U.S. Army Research Laboratory, Aberdeen, MD, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Efrain Hernandez-Rivera
Emily Schueller
5Center for Disease Dynamics, Economics, and Policy, Silver Spring, MD, USA
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yupeng Yang
5Center for Disease Dynamics, Economics, and Policy, Silver Spring, MD, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simon A. Levin
7Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA
8Princeton Environmental Institute, Princeton University, Princeton, NJ, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eili Y. Klein
1Department of Emergency Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
2Center for Data Science in Emergency Medicine, Johns Hopkins University, Baltimore, MD, USA
5Center for Disease Dynamics, Economics, and Policy, Silver Spring, MD, USA
9Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Understanding the transmission dynamics of the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is critical to inform sound policy decisions. We demonstrate how the transmission of undetected cases with pre-symptomatic, asymptomatic and mild symptoms, which are typically underreported due to lower testing capacity, explained the “bomb-like” behavior of exponential growth in the coronavirus disease 2019 (COVID-19) cases during early stages before the effects of large-scale, non-pharmaceutical interventions such as social distancing, school closures, or lockdowns. Using a Bayesian approach to epidemiological compartmental modeling, we captured the initial stages of the pandemic resulting in the explosion of cases and compared the parameter estimation with empirically measured values from the current knowledgebase. Parameter estimation was conducted using Markov chain Monte Carlo (MCMC) sampling methods with a Bayesian inference framework to estimate the proportion of undetected cases. Using data from the exponential phase of the pandemic prior to the implementation of interventions we estimated the basic reproductive number (R0) and symptomatic rates in Italy, Spain, South Korea, New York City, and Chicago. From this modeling study, R0 was estimated to be 3·25 (95% CrI, 1·09-29·77), 3·62 (95% CrI, 1·13-34·89), 2·75 (95% CrI, 1·04-22·44), 3·31 (95% CrI, 1·69-20·55), and 3·46 (95% CrI, 1·01-34·41), respectively. For all locations, 3-25% of infected patients were identified with moderate and severe symptoms in the early stage of the COVID-19 pandemic. Our modeling results support the mounting evidence that potentially large fractions of the infected population were undetected with asymptomatic and mild symptoms. Furthermore, a significant number of models of transmission that do not account for these asymptomatic cases may lead to an underestimation of R0 and, subsequently, policies that do not sufficiently reduce transmission to contain the spread of the virus. Detecting asymptomatic transmission can help slow down the spread of SARS-CoV-2.

Author Summary The spread of SARS-CoV-2 has led to a global pandemic that is still spreading across countries. We fitted a mathematical model to reported infections in Spain, Italy, South Korea, New York, and Chicago before any large-scale interventions, such as lockdowns and school closures, and found that undetected infected individuals drove the accelerated pace of transmissions. Due to the limited capacity in testing in many of the five locations, undetected cases were most likely asymptomatic and mild to moderate symptomatic infections. Given the explosive nature in the number of cases during the early phase of the pandemic and the latest serological surveys, our study suggested that most active cases were undetected. Other cohort studies have shown that a significant proportion of cases reported little or no symptoms. We also showed that early detection of asymptomatic and mild symptomatic cases can lead to a slower spread of SARS-CoV-2 as evident in South Korea. Policies targeting symptomatic individuals, such as travel restrictions on affected areas or quarantines of sick individuals, are not as effective because they neglect asymptomatic transmission events.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by the Centers for Disease Control and Prevention (CDC) MInD-Healthcare Program (Grant Number 1U01CK000536). SL was supported by The National Science Foundation (CCF 1917819). DM was also supported by the Agency for Healthcare Research and Quality (AHRQ) Patient Safety Learning Laboratory program.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Author Contributions EK and GL designed the study. GL, AB, MP, YY, AG, EH and EK developed the model, ran the computations, and analyzed the data. KT, OG, and ES conducted the literature search and data collection. GL, KT, and OG created all the figures. GL, AS, DM, SL, and EK interpreted the results. GL and EK drafted the Article. All authors edited and revised the Article.

  • Updated main manuscript, authors, and added supplement.

Data Availability

Data derived from public domain resources

https://github.com/CSSEGISandData/COVID-19

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted November 23, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Modeling the “Bomb-Like” Dynamics of COVID-19 with Undetected Transmissions and the Implications for Policy
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Modeling the “Bomb-Like” Dynamics of COVID-19 with Undetected Transmissions and the Implications for Policy
Gary Lin, Anindya Bhaduri, Alexandra T. Strauss, Maxwell Pinz, Diego A. Martinez, Katie K. Tseng, Oliver Gatalo, Andrew T. Gaynor, Efrain Hernandez-Rivera, Emily Schueller, Yupeng Yang, Simon A. Levin, Eili Y. Klein, For the CDC MInD-Healthcare Program
medRxiv 2020.04.05.20054338; doi: https://doi.org/10.1101/2020.04.05.20054338
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Modeling the “Bomb-Like” Dynamics of COVID-19 with Undetected Transmissions and the Implications for Policy
Gary Lin, Anindya Bhaduri, Alexandra T. Strauss, Maxwell Pinz, Diego A. Martinez, Katie K. Tseng, Oliver Gatalo, Andrew T. Gaynor, Efrain Hernandez-Rivera, Emily Schueller, Yupeng Yang, Simon A. Levin, Eili Y. Klein, For the CDC MInD-Healthcare Program
medRxiv 2020.04.05.20054338; doi: https://doi.org/10.1101/2020.04.05.20054338

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (280)
  • Allergy and Immunology (577)
  • Anesthesia (139)
  • Cardiovascular Medicine (1942)
  • Dentistry and Oral Medicine (252)
  • Dermatology (183)
  • Emergency Medicine (331)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (697)
  • Epidemiology (11086)
  • Forensic Medicine (8)
  • Gastroenterology (619)
  • Genetic and Genomic Medicine (3156)
  • Geriatric Medicine (307)
  • Health Economics (560)
  • Health Informatics (2037)
  • Health Policy (861)
  • Health Systems and Quality Improvement (781)
  • Hematology (309)
  • HIV/AIDS (682)
  • Infectious Diseases (except HIV/AIDS) (12702)
  • Intensive Care and Critical Care Medicine (707)
  • Medical Education (317)
  • Medical Ethics (92)
  • Nephrology (334)
  • Neurology (2977)
  • Nursing (162)
  • Nutrition (461)
  • Obstetrics and Gynecology (589)
  • Occupational and Environmental Health (614)
  • Oncology (1548)
  • Ophthalmology (474)
  • Orthopedics (185)
  • Otolaryngology (265)
  • Pain Medicine (201)
  • Palliative Medicine (57)
  • Pathology (402)
  • Pediatrics (909)
  • Pharmacology and Therapeutics (381)
  • Primary Care Research (354)
  • Psychiatry and Clinical Psychology (2774)
  • Public and Global Health (5583)
  • Radiology and Imaging (1090)
  • Rehabilitation Medicine and Physical Therapy (630)
  • Respiratory Medicine (755)
  • Rheumatology (338)
  • Sexual and Reproductive Health (311)
  • Sports Medicine (287)
  • Surgery (342)
  • Toxicology (48)
  • Transplantation (159)
  • Urology (131)